We innovate at the exciting intersection of biology, engineering and advanced computation… to deliver breakthrough products and services with world-changing significance. Ours is a comprehensive approach founded on three core capabilities – Biostrategy, Biomeasurement and Biomanufacture.
Biostrategy, Biomeasurement and Biomanufacture
Getting to market as the world transforms
Now more than ever, your route to market must navigate a complex, shifting global landscape. As risks arise, so do the potential rewards. Bioinnovation has the rare capacity to provide clarity and momentum in critical areas of opportunity, such as healthcare, agriculture and climate change.
Ideas are the easier part; making them a reality is harder. The truth is, you require more than good technology to deliver positive change in a commercial context. To get to market, you need robust, realistic strategies. We can help you develop them because we understand the tools (biotechnology), the rules (governance models) and the interests (economic models) involved. Aligning all three is the secret to business success in Bioinnovation.
Gaining insight with better information
Bioinnovation relies absolutely on Biomeasurement. It is the bedrock that enables control and optimization. But biological systems are extremely complex, span a huge scale range from km to nm and are incredibly difficult to measure. Success relies on seamless integration across numerous disciplines at which we are adept – including wetware, hardware and software.
Our unique blend of abilities helps you bring new measurement and diagnosis products to market or integrate new measurement tools into your process and catalyze productivity gains. We understand and develop innovative sensors and cutting-edge data analysis. We’re able to bring together molecular biology, assay development, physics, electronics and AI to achieve the most complex measurements. And we package them for you in robust, easy-to-use, cost-effective solutions that comply with stringent regulatory requirements, including cGMP and medical device quality systems.
Scaling up and delivering at viable cost
Researchers are continually discovering new ways to apply biology in their pursuit of breakthrough innovation. The real challenge is moving complex processes from the lab to high-volume manufacture at a cost that delivers business viability. Experience tells us that successful scale up demands optimization and invention across all disciplines – including biology, hardware, usability and control systems – plus rigorous regulatory compliance.
We can help you optimize processes and develop the custom equipment you need to deliver at commercial cost and scale. We work seamlessly across biology, process optimization and equipment design to enable the successful manufacture and delivery of your product or advanced medical therapy.
Talk to us about world-changing science
Proven in biodesign
Our proven biodesign capability has grown organically from our long history in healthcare and life sciences. Few if any of our peers can match our holistic approach which adds biodesign to the complementary disciplines of engineering and computation. This unique breadth of expertise offers significant advantages that speed and ease your path to biomanufacture.
Antha is a programming language for biology. It describes and executes complex workflows, driving massive productivity gains during biodesign. We are long-term partners with Synthace and use Antha in our labs. We can help you discover the power of Antha to unlock your science and gather the data you need without limits.
Meet the core team
"Biotechnology has the ability to unlock products that improve our lives in ways that have never been possible before."
"Taking the big picture view, we want to help biotech companies get more products to market, in less time and for lower cost."
"As a biologist, I love being able to collaborate with colleagues with a vast array of skills and knowledge. Innovation is enabled by the multidisciplinary nature of CC and constantly being asked ‘but why?’ and ‘what else?’. Providing novel solutions to real world problems is very much at the heart of CC."
“Biotech has the potential to reshape the global economy and transform every sector in profound ways. Convergence of deep-technologies can enable and accelerate this. Working with our ambitious clients to realise their ideas and discoveries is tremendously rewarding.”
"Our clients are diverse, the science they are trying to deliver is novel. Every project brings the opportunity to gain a new understanding."
Tech, tools & facilities
我们设在剑桥总部的微生物实验室使我们可以对微生物进行基因改造和特征描述。我们的设施达到了致病性菌株处理二级防护级别，我们的内部库令快速模块化 DNA 构建设计和组装成为可能。构建有机体，令其成为医疗保健和生物技术应用领域的生物传感器，是我们特别感兴趣的一个课题。
我们专门为在受控和管制的环境中处理和试验药物、受管制物质、生物危害物和人类样本而设计了一系列严格管理的 II 类实验室。我们的仪器室配备了计量、显微镜和产品测试设备，可以对原型和产品实施严格的验证和品控。
Enabling the world's first DNA-based platform for massive data storage.
Harnessing the science of synthetic biology and best-in-class automation to turn organic waste into high-protein fish food.
Developing biology-based sensors as a cost effective, long-term solution for monitoring environmental public health risks.
News & insights
Cambridge Consultants announces its collaboration with MedTech Innovator, a world-leading non-profit start-up accelerator
Cambridge Consultants part of Capgemini, today announced its collaboration with MedTech Innovator Asia Pacific, the world’s leading non-profit accelerator of medical devices.
Scale-down models have become an increasingly common development tool, especially in the bioprocessing industry. Read our eBook to discover our approach to the challenge of scaling up scale down models.
Cambridge Consultants & Kytopen announce the initial release of the Flowfect™ Tx System, a breakthrough that will help deliver the full promise of cell therapies to tackle disease.
Synthetic biology remains nascent, yet full of promise. The idea of using rational engineering approaches to design biology has the potential to solve some of humanity’s biggest challenges, such as securing food supplies...